CVS slashes price of Impax’s EpiPen rival

From Reuters:

Drugstore chain CVS Health Corp (CVS.N) has cut the price of a generic version of Impax Laboratories Inc’s (IPXL.O) emergency allergy injection, a device similar to Mylan NV’s (MYL.O) controversial EpiPen.

Mylan, which has been lambasted by consumers and lawmakers for raising EpiPen prices six-fold in less than a decade, said last month it would start selling a generic version of EpiPen for $300 per two-pack, a more than 50 percent discount.

CVS’s move comes after health insurer Cigna Corp (CI.N) revised its coverage list to include the generic version of Epipen instead of the branded version.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: